These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7935928)

  • 21. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 22. [FACT study: benefits of alendronate].
    MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.
    Thomas T; Lafage MH; Alexandre C
    J Rheumatol; 1995 Nov; 22(11):2183-5. PubMed ID: 8596168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of postmenopausal osteoporosis with etidronate].
    Terranova R; Luca S
    Minerva Med; 1999 Mar; 90(3):85-90. PubMed ID: 10432959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622
    [No Abstract]   [Full Text] [Related]  

  • 26. [To treat effectively without delay. The data on fractures decisive].
    MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment options for postmenopausal osteoporosis.
    Singer F
    Hawaii Med J; 1994 Sep; 53(9):256-7, 260-1. PubMed ID: 7960721
    [No Abstract]   [Full Text] [Related]  

  • 28. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture].
    MMW Fortschr Med; 2001 May; 143(18):53. PubMed ID: 11393183
    [No Abstract]   [Full Text] [Related]  

  • 30. Iatrogenic osteoporosis.
    Hamdy RC
    South Med J; 1999 Nov; 92(11):1131-3. PubMed ID: 10586849
    [No Abstract]   [Full Text] [Related]  

  • 31. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T; Kollerup G; Thamsborg G; Genant HK; Sørensen OH
    J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis.
    Brown JP; Kendler DL; McClung MR; Emkey RD; Adachi JD; Bolognese MA; Li Z; Balske A; Lindsay R
    Calcif Tissue Int; 2002 Aug; 71(2):103-11. PubMed ID: 12085156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent cyclic etidronate treatment of postmenopausal osteoporosis.
    Sternberg JL
    Am J Med; 1995 Sep; 99(3):333-4. PubMed ID: 7653501
    [No Abstract]   [Full Text] [Related]  

  • 34. Risedronate: a new bisphosphonate for the treatment of osteoporosis.
    Kessenich CR
    Nurse Pract; 2000 Mar; 25(3):106-8. PubMed ID: 10750124
    [No Abstract]   [Full Text] [Related]  

  • 35. [Osteoporosis therapy. A comparison of bisphosphonates].
    MMW Fortschr Med; 2002 Jul; 144(27-28):60. PubMed ID: 12198889
    [No Abstract]   [Full Text] [Related]  

  • 36. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis.
    Loeliger EA
    Am J Med; 1995 Aug; 99(2):225-6. PubMed ID: 7677912
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study indites calcium as a heart breaker. 30 % more myocardial infarcts caused by high dosage calcium preparations].
    Kinderkrankenschwester; 2013 Mar; 32(3):114. PubMed ID: 23600116
    [No Abstract]   [Full Text] [Related]  

  • 38. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA; Amonkar MM; Hebborn A; Altman R
    Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications for postmenopausal osteoporosis prevention.
    Harv Womens Health Watch; 2002 Dec; 10(4):6-7. PubMed ID: 12499127
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of osteoporosis. Risk factors alone are not an indication].
    MMW Fortschr Med; 2001 Dec; 143(49-50):57. PubMed ID: 11813710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.